• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$50.49 -$0.13 (-0.26%)

REAL-TIME: Last trade at

Gilead Sciences

NASDAQ:GILD

GILD vs. S&P 500
$50.49 -$0.13 (-0.26%)
Today's Open $50.74
Previous Close $50.62
Daily Range $50.18 - $50.76
52-Week Range $34.45 - $56.50
Market Cap $38.2B
P/E Ratio 15.25
Dividend (Yield) $0.00 (0.0%)
Volume 2,882,525
Average Daily Volume 7,653,562
Current FY EPS $3.43

Sector

Healthcare

Industry

Biotechnology

Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.

News & Commentary

GILD's Top Competitors

GILD

$50.49 (-0.26%)

Current stock: GILD
AMGN

$69.05 (-0.07%)

Current stock: AMGN
CELG

$68.90 (-1.44%)

Current stock: CELG
GENZ.DL

$76.25 (0.00%)

Current stock: GENZ.DL